Last updated: 4 months ago
Applied DNA Sciences Q4 2023 Report: Restructuring Amidst Financial Challenges
Explore Applied DNA Sciences, Inc.'s Q4 2023 financial results, highlighting revenue drops, a net loss, workforce reduction, and strategic shifts. Stock recommendation: Hold.